BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27786407)

  • 1. Defining disparities in liver transplantation: The devil is in the details.
    Goldberg DS
    Liver Transpl; 2016 Dec; 22(12):1720-1723. PubMed ID: 27786407
    [No Abstract]   [Full Text] [Related]  

  • 2. Model for end-stage liver disease exceptions: proceed with caution.
    Washburn K
    Liver Transpl; 2011 Oct; 17(10):1123-4. PubMed ID: 21837739
    [No Abstract]   [Full Text] [Related]  

  • 3. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices.
    Cholankeril G; Yoo ER; Perumpail RB; Younossi ZM; Ahmed A
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):313-315. PubMed ID: 27609705
    [No Abstract]   [Full Text] [Related]  

  • 4. Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?
    Vining CC; Ecker BL; Abt PL; Olthoff KM
    Liver Transpl; 2017 Oct; 23(S1):S27-S33. PubMed ID: 28846212
    [No Abstract]   [Full Text] [Related]  

  • 5. Who should get a liver graft?
    Freeman RB; Jamieson N; Schaubel DE; Porte RJ; Villamil FG
    J Hepatol; 2009 Apr; 50(4):664-73. PubMed ID: 19233503
    [No Abstract]   [Full Text] [Related]  

  • 6. [The MELD system and organ allocation policy: lessons after the first year of use in the United States].
    Tome S; Botero RC; Lucey MR
    Gastroenterol Hepatol; 2004 Jan; 27(1):35-40. PubMed ID: 14718108
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver transplantation in the ethnic minority population: challenges and prospects.
    Kemmer N; Neff GW
    Dig Dis Sci; 2010 Apr; 55(4):883-9. PubMed ID: 19390965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States.
    Heimbach JK; Hirose R; Stock PG; Schladt DP; Xiong H; Liu J; Olthoff KM; Harper A; Snyder JJ; Israni AK; Kasiske BL; Kim WR
    Hepatology; 2015 May; 61(5):1643-50. PubMed ID: 25644186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lethal and enduring inequity of deceased donor liver allocation policy for hepatocellular carcinoma in the United States.
    Charlton M
    Am J Transplant; 2013 Nov; 13(11):2794-6. PubMed ID: 24119018
    [No Abstract]   [Full Text] [Related]  

  • 10. Who should get a liver graft?
    Clavien PA
    J Hepatol; 2009 Apr; 50(4):662-3. PubMed ID: 19233502
    [No Abstract]   [Full Text] [Related]  

  • 11. Candidate selection and organ allocation in liver transplantation.
    Dawwas MF; Gimson AE
    Semin Liver Dis; 2009 Feb; 29(1):40-52. PubMed ID: 19235658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in Germany.
    Tacke F; Kroy DC; Barreiros AP; Neumann UP
    Liver Transpl; 2016 Aug; 22(8):1136-42. PubMed ID: 27082951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying expanded criteria to liver transplantation for hepatocellular carcinoma: too much too soon, or is now the time?
    Yao FY; Roberts JP
    Liver Transpl; 2004 Jul; 10(7):919-21. PubMed ID: 15237378
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
    Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
    Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited commentary.
    Freeman RB
    J Am Coll Surg; 2015 Jun; 220(6):1007-9. PubMed ID: 25998078
    [No Abstract]   [Full Text] [Related]  

  • 17. [Selection criteria decisive in hepatocellular carcinoma].
    Söderdahl G; Eilard MS; Rizell M
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1750-3. PubMed ID: 23097883
    [No Abstract]   [Full Text] [Related]  

  • 18. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Dupuis-Lozeron E; Majno P; Berney T; Kneteman NM; Perneger T; Morel P; Mentha G; Combescure C
    Hepatology; 2012 Jul; 56(1):149-56. PubMed ID: 22271250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Top ten facts you need to know: about liver transplantation.
    Butt FK; Earl TM; Anderson CD
    J Miss State Med Assoc; 2014 Jul; 55(7):212-5. PubMed ID: 25252424
    [No Abstract]   [Full Text] [Related]  

  • 20. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.